Bryce Joanne 4
4 · Disc Medicine, Inc. · Filed Sep 5, 2023
Insider Transaction Report
Form 4
Bryce Joanne
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-09-01−1,000→ 3,753 totalExercise: $2.65Exp: 2030-10-22→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2023-09-01$2.65/sh+1,000$2,650→ 2,260 total - Sale
Common Stock
2023-09-01$52.99/sh−1,000$52,990→ 1,260 total
Footnotes (2)
- [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 15, 2023.
- [F2]The shares underlying this option vest in 48 equal monthly installments following October 7, 2020, subject to the Reporting Person's continued service on each such vesting date.